Risk factors for fracture in a UK population: a prospective cohort study

Jill Porthouse(University of York), Ian Watt(University of York), Suezann Puffer(University of York), Sarah Cockayne(University of York), Yvonne Birks(University of York), David Torgerson(University of York)

QJM

August 18, 2004

10.1093/qjmed/hch097

Cited by 77

Related Papers

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

|Osteoporosis International|2007|1.2k

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

|The Lancet|2005|976

CONSORT 2025 statement: updated guideline for reporting randomised trials

|BMJ|2025|847

Guidelines for diagnosis and management of osteoporosis

|Osteoporosis International|1997|793

Understanding controlled trials: What are pragmatic trials?

|BMJ|1998|721